Bifiform capsules, 40pcs

Composition

Active ingredients: Enterococcus faecium Bifidobacterium longum Auxiliary substances: dextrose anhydrous 162.5 mg, yeast starter culture 17.5 mg, carob bean gum 12.5 mg, magnesium stearate 2.5 mg, lactulose 0.5 mg. Composition of the capsule shell: gelatin 48.0 mg, titanium dioxide (0.96 mg)*, magnesium stearate 0.5 mg, methacrylic acid and methyl methacrylate copolymer [1: 1] 2.2 mg, methacrylic acid and ethyl acrylate copolymer [1: 1] [30% dispersion] 7.7 mg, talc 5.6 mg, macrogol 6000 1.5 mg, refined soybean oil 0.8 mg, diacetylated glycerides 0.3 mg. *titanium dioxide is included in the total mass of the gelatin capsule.

Pharmacological action

Enterococcus faecium and Bifidobacterium longum strains, which are part of the drug, are natural symbiotic bacteria that inhabit the gastrointestinal tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora. The effect is due to both the direct direct effect of the components included in the preparation (high antagonistic activity against pathogenic and conditionally pathogenic microorganisms) and indirect – stimulation of local intestinal immunity (activation of immunoglobulin A synthesis, induction of endogenous interferon synthesis). Bifidobacterium longum has a high survival rate in the human gut and a high growth rate. The inclusion in the preparation of apathogenic enterococcus faecium, which normally colonizes the small intestine, can have a positive effect on the condition and digestive functions of not only the large intestine, but also the small intestine, especially in the presence of fermentation dyspepsia and flatulence phenomena.

Indications

Diarrhea caused by acute and acute exacerbation of chronic gastroenteritis, rotavirus infection;- in the complex therapy of acute intestinal infections; – in the complex therapy of chronic diseases of the gastrointestinal tract, such as colitis, irritable bowel syndrome and other gastrointestinal disorders of functional genesis; – normalization of intestinal microflora, treatment and prevention of dysbiosis and maintenance of the immune system in children over 2 years of age and adults; – lactose intolerance;- as part of complex standard eradication therapy in patients with Helicobacter pylori infection.

Contraindications

Individual hypersensitivity to the components of the drug.

How to take, course of use and dosage

In acute diarrhea, the drug should be taken 1 capsule 4 times a day until the stool normalizes. Then the drug should be continued at a dose of 2-3 capsules per day until the symptoms completely disappear. To normalize the intestinal microflora and support the immune system, the drug is prescribed in a dose of 2-3 capsules per day for 10-21 days. Patients with lactose intolerance are recommended to take the drug 1 capsule 3 times a day. When conducting eradication therapy, Bifiform is prescribed 2 capsules 2 times a day for two weeks from the first day of eradication therapy. Children from 2 years of age: 1 capsule 2-3 times a day. The duration of admission can be adjusted according to the doctor’s recommendation. When prescribing to children and patients who cannot swallow a whole capsule, it should be carefully broken, carefully, avoiding losses, pour the contents into a spoon and mix with a small amount of liquid. If you have any questions, please consult your doctor.

Description

Bifiform® is an effective drug for the treatment of dysbiosis! Benefits of the drug: Studied bacteria: The drug contains studied, safe and useful probiotic bacteria from the leading microbiological laboratory “Christian Hansen” (Denmark). Double-layer protective shell: The Bifiform ® capsule has a two-layer protective shell, thanks to which the entire complex of beneficial probiotic bacteria is delivered to the intestines. Bacteria are not destroyed by the acidic environment of the stomach and retain their beneficial properties when they enter the intestines. Special nutrient medium for beneficial bacteria: In addition to beneficial bacteria, Bifiform® contains a special nutrient medium for their nutrition, growth and reproduction. Bifiform® does not contain lactose due to food intake.

Active ingredient

of Bifidobacteria longum, Enterococcus fecium

Dosage form

Capsules

Description

Children over 2 years old, For adults

Indications

Diarrhea, Intestinal Infections, Enteritis, Gastrointestinal Infections caused by Helicobacter Pylori, Colitis, Dysbiosis